June 23, 2021—RapidPulse, Inc. announced the closing of a $15 million Series A financing that the company plans to use to advance its RapidPulse cyclic aspiration system through expanded clinical evaluation and build out its platform of proprieta…
June 23, 2021—Penumbra, Inc. announced FDA 510(k) clearance and commercial availability of the Red 62 reperfusion catheter, an addition to the Penumbra system for mechanical thrombectomy.
According to the company, Red 62 is designed to navigat…
June 21, 2021—Sensome announced that it has been granted a Breakthrough Device designation by FDA for its Clotild smart guidewire system, which is designed to use artificial intelligence (AI) to improve the treatment of ischemic stroke patients.
On 19 March, the first patient was included in the BeGraft fenestrated endovascular aneurysm repair (FEVAR) study investigating the Bentley BeGraft peripheral balloon expandable covered stent in complex aortic aneurysms. The patient was referred for FEVAR with a 6cm juxtarenal abdominal aortic aneurysm, explained the coordinating investigator and study lead, Eric Verhoeven (General Hospital Nuremberg, […]
The post First patient treated in the BeGraft FEVAR study aimed at providing evidence for on-label use appeared first on Vascular News.
Cagent Vascular recently announced the investment of US$9 million by Sectoral Asset Management. Along with the investment, Marc-Andre Marcotte has joined the board of directors. The proceeds will be used to accelerate the commercialisation and scaling of manufacturing for the Serranator below-the-knee (BTK) product. Further uses of proceeds include expanding the product offering to include […]
The post Sectoral Asset Management makes US$9 million investment into Cagent Vascular appeared first on Vascular News.
According to a new, population-based analysis, abdominal aortic aneurysm (AAA) mortality has continued to decline and “at a faster rate than ever” in the second decade of the 21st century. Authors C Y Maximilian Png (Massachusetts General Hospital, Boston, USA), Edward Choke (Sengkang General Hospital, Singapore), and colleagues attribute this continued and accelerating decline to […]
The post Large study shows continued and quickening decline in AAA mortality appeared first on Vascular News.
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is the primary conclusion of Tanner I Kim (Yale School of Medicine, New Haven, USA) and colleagues, writing in an article recently published online in the Journal of Vascular Surgery. The […]
June 15, 2021—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced findings demonstrating that a new positron emission tomography (PET) radiotracer can detect abdominal aortic aneurysms (AAAs) and potentially predict when they …
A pooled meta-analysis found that patients with symptomatic carotid stenosis enrolled in recent randomised controlled trials (RCTs) had a lower risk of stroke after randomisation than historical controls. According to authors Urs Fisch (University of Basel, Basel, Switzerland) and colleagues, their findings add to the current evidence that the risk of stroke associated with symptomatic […]
This advertorial, sponsored by BD, is intended for healthcare professionals in Europe only. “Improving vessel compliance with focused force longitudinal plaque fracture seems to be a promising strategy instead of standard percutaneous transluminal angioplasty [PTA],” states interventional angiologist Michael Lichtenberg (Arnsberg Vascular Center, Arnsberg, Germany), detailing that the technique avoids “significant vessel damage”. In this […]
The post Case report: Recanalisation of a long SFA occlusion with Ultrascore™ Focused Force PTA Balloon lesion preparation and Lutonix™ 018 Drug Coated Balloon angioplasty appeared first on Vascular News.